| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | phosphatidylserine flippase activity | 1.44e-05 | 5 | 228 | 3 | GO:0140346 | |
| GeneOntologyMolecularFunction | minus-end-directed microtubule motor activity | 4.47e-05 | 18 | 228 | 4 | GO:0008569 | |
| GeneOntologyMolecularFunction | aminophospholipid flippase activity | 4.97e-05 | 7 | 228 | 3 | GO:0015247 | |
| GeneOntologyMolecularFunction | phosphatidylethanolamine flippase activity | 4.97e-05 | 7 | 228 | 3 | GO:0090555 | |
| GeneOntologyMolecularFunction | ATP hydrolysis activity | KIF1A ABCA13 ATP8A2 KIF1B ABCA8 ATP11C ATP11A ATP13A3 DNAH9 DNAH3 ABCB6 CHD8 HELQ DNAH12 ATAD1 HSP90AB2P | 5.06e-05 | 441 | 228 | 16 | GO:0016887 |
| GeneOntologyMolecularFunction | dynein intermediate chain binding | 6.01e-05 | 37 | 228 | 5 | GO:0045505 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | KIF1A MYO7A ABCA13 ATP8A2 KIF1B ABCA8 ACSF3 ATP11C ATP11A ATP13A3 DNAH9 DNAH3 ABCB6 CHD8 HELQ DNAH12 ATAD1 DNAH17 HSP90AB2P | 8.59e-05 | 614 | 228 | 19 | GO:0140657 |
| GeneOntologyMolecularFunction | phosphatidylserine floppase activity | 1.17e-04 | 9 | 228 | 3 | GO:0090556 | |
| GeneOntologyMolecularFunction | microtubule motor activity | 1.48e-04 | 70 | 228 | 6 | GO:0003777 | |
| GeneOntologyMolecularFunction | dynein light intermediate chain binding | 2.73e-04 | 28 | 228 | 4 | GO:0051959 | |
| GeneOntologyMolecularFunction | intramembrane lipid transporter activity | 2.85e-04 | 51 | 228 | 5 | GO:0140303 | |
| GeneOntologyMolecularFunction | cytoskeletal motor activity | 4.16e-04 | 118 | 228 | 7 | GO:0003774 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 4.35e-04 | 196 | 228 | 9 | GO:0005319 | |
| GeneOntologyMolecularFunction | glycerophospholipid flippase activity | 4.87e-04 | 14 | 228 | 3 | GO:0140333 | |
| GeneOntologyMolecularFunction | phosphotransferase activity, alcohol group as acceptor | SMG1 NT5C3A ITK RPS6KC1 TAOK3 PIK3CA UCKL1 SYK MAP3K9 PRKD2 NPR2 KSR2 TGFBR2 NRBP2 IGF2R TBK1 NT5C2 SRPK3 MAPK4 | 5.27e-04 | 709 | 228 | 19 | GO:0016773 |
| GeneOntologyMolecularFunction | floppase activity | 7.37e-04 | 16 | 228 | 3 | GO:0140328 | |
| GeneOntologyMolecularFunction | putrescine transmembrane transporter activity | 7.67e-04 | 4 | 228 | 2 | GO:0015489 | |
| GeneOntologyMolecularFunction | flippase activity | 8.88e-04 | 17 | 228 | 3 | GO:0140327 | |
| GeneOntologyMolecularFunction | nucleotidase activity | 1.06e-03 | 18 | 228 | 3 | GO:0008252 | |
| GeneOntologyMolecularFunction | histone H3K9me/H3K9me2 demethylase activity | 1.27e-03 | 5 | 228 | 2 | GO:0140683 | |
| GeneOntologyBiologicalProcess | aminophospholipid transport | 1.72e-06 | 9 | 227 | 4 | GO:0015917 | |
| GeneOntologyBiologicalProcess | intracellular transport | SMG1 AHCYL1 INTU KIF1A MYO7A VPS13C KIF1B GCKR ACTN2 KCNIP3 NF1 CEP120 CLN5 VPS13A NXF3 SYK KCNQ2 DENND5A HERC2 RGPD5 RPH3AL RGPD8 FERMT1 CPT1B NCOA4 DENND1A WDR91 IGF2R CSE1L IGHG3 IGHG4 SCARB2 RIMS1 LRBA BBS12 SIX2 HTT | 2.86e-06 | 1496 | 227 | 37 | GO:0046907 |
| GeneOntologyCellularComponent | lysosome | MYO7A ARSK ABCA13 VPS13C RPS6KC1 CLN5 VPS13A ATP11C ATP11A NOS1 CAP1 WDR48 ABCB6 CP APOB NCOA4 USP6 SCARB2 NPRL3 LRRC8A LRBA CTSH | 8.97e-05 | 811 | 229 | 22 | GO:0005764 |
| GeneOntologyCellularComponent | lytic vacuole | MYO7A ARSK ABCA13 VPS13C RPS6KC1 CLN5 VPS13A ATP11C ATP11A NOS1 CAP1 WDR48 ABCB6 CP APOB NCOA4 USP6 SCARB2 NPRL3 LRRC8A LRBA CTSH | 8.97e-05 | 811 | 229 | 22 | GO:0000323 |
| GeneOntologyCellularComponent | axonemal dynein complex | 1.48e-04 | 25 | 229 | 4 | GO:0005858 | |
| GeneOntologyCellularComponent | vacuole | MYO7A ARSK ABCA13 VPS13C RPS6KC1 CLN5 VPS13A ATP11C ATP11A NOS1 CAP1 WDR48 ABCB6 CP APOB NCOA4 USP6 SCARB2 NPRL3 LRRC8A LRBA CTSH HTT | 1.84e-04 | 913 | 229 | 23 | GO:0005773 |
| GeneOntologyCellularComponent | phospholipid-translocating ATPase complex | 4.32e-04 | 14 | 229 | 3 | GO:1990531 | |
| Domain | PH_dom-like | KIF1A MYO7A KIF1B ITK PLCG2 PLEKHH2 FERMT2 NSMAF FERMT3 RGPD5 PRKD2 RGPD8 RASA1 FERMT1 NBEA PLEKHG2 WDFY4 LRBA PHLPP2 | 9.29e-07 | 426 | 223 | 19 | IPR011993 |
| Domain | PH_BEACH | 1.33e-06 | 8 | 223 | 4 | PS51783 | |
| Domain | PH-BEACH_dom | 1.33e-06 | 8 | 223 | 4 | IPR023362 | |
| Domain | - | 1.33e-06 | 8 | 223 | 4 | 2.30.29.40 | |
| Domain | BEACH | 2.38e-06 | 9 | 223 | 4 | PS50197 | |
| Domain | Beach | 2.38e-06 | 9 | 223 | 4 | SM01026 | |
| Domain | BEACH_dom | 2.38e-06 | 9 | 223 | 4 | IPR000409 | |
| Domain | Beach | 2.38e-06 | 9 | 223 | 4 | PF02138 | |
| Domain | - | 2.38e-06 | 9 | 223 | 4 | 1.10.1540.10 | |
| Domain | - | 1.10e-05 | 64 | 223 | 7 | 3.40.50.1000 | |
| Domain | Autophagy-rel_C | 1.65e-05 | 5 | 223 | 3 | IPR015412 | |
| Domain | ATG_C | 1.65e-05 | 5 | 223 | 3 | PF09333 | |
| Domain | HAD-like_dom | 4.40e-05 | 79 | 223 | 7 | IPR023214 | |
| Domain | Chorein_N | 9.00e-05 | 8 | 223 | 3 | PF12624 | |
| Domain | VPS13_N | 9.00e-05 | 8 | 223 | 3 | IPR026854 | |
| Domain | PH | KIF1A KIF1B ITK PLCG2 PLEKHH2 FERMT2 FERMT3 PRKD2 RASA1 FERMT1 PLEKHG2 | 1.01e-04 | 229 | 223 | 11 | PF00169 |
| Domain | PH_DOMAIN | KIF1A KIF1B ITK PLCG2 PLEKHH2 FERMT2 FERMT3 PRKD2 RASA1 FERMT1 PLEKHG2 PHLPP2 | 1.40e-04 | 279 | 223 | 12 | PS50003 |
| Domain | Thr_synth_N | 1.42e-04 | 2 | 223 | 2 | PF14821 | |
| Domain | K_chnl_volt-dep_KCNQ2 | 1.42e-04 | 2 | 223 | 2 | IPR003947 | |
| Domain | - | 1.42e-04 | 2 | 223 | 2 | 3.90.1380.10 | |
| Domain | XAP5 | 1.42e-04 | 2 | 223 | 2 | IPR007005 | |
| Domain | Thr_synthase-like | 1.42e-04 | 2 | 223 | 2 | IPR004450 | |
| Domain | DUF1088 | 1.42e-04 | 2 | 223 | 2 | PF06469 | |
| Domain | Thr_synth_N | 1.42e-04 | 2 | 223 | 2 | IPR029144 | |
| Domain | DUF1088 | 1.42e-04 | 2 | 223 | 2 | IPR010508 | |
| Domain | XAP5 | 1.42e-04 | 2 | 223 | 2 | PF04921 | |
| Domain | FERM_M | 2.13e-04 | 46 | 223 | 5 | PF00373 | |
| Domain | - | KIF1A MYO7A KIF1B ITK PLCG2 PLEKHH2 FERMT2 FERMT3 PRKD2 RGPD8 RASA1 FERMT1 PLEKHG2 PHLPP2 | 2.68e-04 | 391 | 223 | 14 | 2.30.29.30 |
| Domain | - | 2.88e-04 | 49 | 223 | 5 | 1.20.80.10 | |
| Domain | FERM_central | 2.88e-04 | 49 | 223 | 5 | IPR019748 | |
| Domain | ConA-like_dom | LAMA1 TRIM34 TRIM77 TRIM6 SEL1L3 NBEA TRIM5 TRIM9 CNTNAP2 LRBA | 3.12e-04 | 219 | 223 | 10 | IPR013320 |
| Domain | FERM/acyl-CoA-bd_prot_3-hlx | 3.17e-04 | 50 | 223 | 5 | IPR014352 | |
| Domain | FERM_1 | 3.17e-04 | 50 | 223 | 5 | PS00660 | |
| Domain | FERM_2 | 3.17e-04 | 50 | 223 | 5 | PS00661 | |
| Domain | FERM_3 | 3.17e-04 | 50 | 223 | 5 | PS50057 | |
| Domain | Band_41_domain | 3.17e-04 | 50 | 223 | 5 | IPR019749 | |
| Domain | B41 | 3.17e-04 | 50 | 223 | 5 | SM00295 | |
| Domain | VPS13_N2 | 4.22e-04 | 3 | 223 | 2 | IPR031646 | |
| Domain | VPS13_mid_rpt | 4.22e-04 | 3 | 223 | 2 | IPR031642 | |
| Domain | VPS13 | 4.22e-04 | 3 | 223 | 2 | IPR026847 | |
| Domain | VPS13_mid_rpt | 4.22e-04 | 3 | 223 | 2 | PF16910 | |
| Domain | VPS13 | 4.22e-04 | 3 | 223 | 2 | PF16908 | |
| Domain | WD40_repeat | HERC2 WDR1 NSMAF WDR48 NWD1 WDR88 NBEA WDFY4 WDR91 LRBA MAPKBP1 | 4.45e-04 | 272 | 223 | 11 | IPR001680 |
| Domain | WD_REPEATS_1 | HERC2 WDR1 NSMAF WDR48 NWD1 WDR88 NBEA WDFY4 WDR91 LRBA MAPKBP1 | 5.35e-04 | 278 | 223 | 11 | PS00678 |
| Domain | PH | KIF1A KIF1B ITK PLCG2 PLEKHH2 FERMT2 FERMT3 PRKD2 RASA1 FERMT1 PLEKHG2 | 5.35e-04 | 278 | 223 | 11 | SM00233 |
| Domain | - | 5.47e-04 | 32 | 223 | 4 | 3.40.1110.10 | |
| Domain | - | 5.47e-04 | 32 | 223 | 4 | 2.70.150.10 | |
| Domain | WD_REPEATS_2 | HERC2 WDR1 NSMAF WDR48 NWD1 WDR88 NBEA WDFY4 WDR91 LRBA MAPKBP1 | 5.51e-04 | 279 | 223 | 11 | PS50082 |
| Domain | WD_REPEATS_REGION | HERC2 WDR1 NSMAF WDR48 NWD1 WDR88 NBEA WDFY4 WDR91 LRBA MAPKBP1 | 5.51e-04 | 279 | 223 | 11 | PS50294 |
| Domain | P_typ_ATPase_c | 5.55e-04 | 14 | 223 | 3 | IPR032630 | |
| Domain | P-type_ATPase_N | 5.55e-04 | 14 | 223 | 3 | IPR032631 | |
| Domain | ATPase_dyneun-rel_AAA | 5.55e-04 | 14 | 223 | 3 | IPR011704 | |
| Domain | AAA_8 | 5.55e-04 | 14 | 223 | 3 | PF12780 | |
| Domain | PhoLip_ATPase_C | 5.55e-04 | 14 | 223 | 3 | PF16212 | |
| Domain | PhoLip_ATPase_N | 5.55e-04 | 14 | 223 | 3 | PF16209 | |
| Domain | RasGAP_CS | 5.55e-04 | 14 | 223 | 3 | IPR023152 | |
| Domain | AAA_5 | 5.55e-04 | 14 | 223 | 3 | PF07728 | |
| Domain | RasGAP | 5.55e-04 | 14 | 223 | 3 | SM00323 | |
| Domain | Dynein_heavy_chain_D4_dom | 5.55e-04 | 14 | 223 | 3 | IPR024317 | |
| Domain | Dynein_heavy_dom-2 | 5.55e-04 | 14 | 223 | 3 | IPR013602 | |
| Domain | DHC_N2 | 5.55e-04 | 14 | 223 | 3 | PF08393 | |
| Domain | P-type_ATPase_IV | 5.55e-04 | 14 | 223 | 3 | IPR006539 | |
| Domain | PH_domain | KIF1A KIF1B ITK PLCG2 PLEKHH2 FERMT2 FERMT3 PRKD2 RASA1 FERMT1 PLEKHG2 | 5.67e-04 | 280 | 223 | 11 | IPR001849 |
| Domain | RasGAP | 6.87e-04 | 15 | 223 | 3 | PF00616 | |
| Domain | RAS_GTPASE_ACTIV_2 | 6.87e-04 | 15 | 223 | 3 | PS50018 | |
| Domain | DHC_fam | 6.87e-04 | 15 | 223 | 3 | IPR026983 | |
| Domain | RAS_GTPASE_ACTIV_1 | 6.87e-04 | 15 | 223 | 3 | PS00509 | |
| Domain | Dynein_heavy | 6.87e-04 | 15 | 223 | 3 | PF03028 | |
| Domain | Dynein_heavy_dom | 6.87e-04 | 15 | 223 | 3 | IPR004273 | |
| Domain | ATPase_P-typ_cyto_domN | 7.75e-04 | 35 | 223 | 4 | IPR023299 | |
| Domain | VPS13_C | 8.38e-04 | 4 | 223 | 2 | IPR031645 | |
| Domain | Kinesin-like_KIF1-typ | 8.38e-04 | 4 | 223 | 2 | IPR022140 | |
| Domain | SHR-BD | 8.38e-04 | 4 | 223 | 2 | IPR009543 | |
| Domain | KIF1B | 8.38e-04 | 4 | 223 | 2 | PF12423 | |
| Domain | VPS13_C | 8.38e-04 | 4 | 223 | 2 | PF16909 | |
| Domain | SHR-BD | 8.38e-04 | 4 | 223 | 2 | PF06650 | |
| Domain | ATPase_P-typ_P_site | 8.63e-04 | 36 | 223 | 4 | IPR018303 | |
| Domain | P_typ_ATPase | 8.63e-04 | 36 | 223 | 4 | IPR001757 | |
| Domain | ATPASE_E1_E2 | 8.63e-04 | 36 | 223 | 4 | PS00154 | |
| Domain | ANF_lig-bd_rcpt | 9.59e-04 | 37 | 223 | 4 | IPR001828 | |
| Domain | ANF_receptor | 9.59e-04 | 37 | 223 | 4 | PF01094 | |
| Domain | ATPase_P-typ_transduc_dom_A | 9.59e-04 | 37 | 223 | 4 | IPR008250 | |
| Domain | E1-E2_ATPase | 9.59e-04 | 37 | 223 | 4 | PF00122 | |
| Domain | WD40 | 1.14e-03 | 259 | 223 | 10 | PF00400 | |
| Domain | Peripla_BP_I | 1.17e-03 | 39 | 223 | 4 | IPR028082 | |
| Domain | RasGAP_dom | 1.20e-03 | 18 | 223 | 3 | IPR001936 | |
| Domain | K_chnl_volt-dep_KCNQ_C | 1.39e-03 | 5 | 223 | 2 | IPR013821 | |
| Domain | K_chnl_volt-dep_KCNQ | 1.39e-03 | 5 | 223 | 2 | IPR003937 | |
| Domain | DUF4704 | 1.39e-03 | 5 | 223 | 2 | IPR031570 | |
| Domain | DUF4704 | 1.39e-03 | 5 | 223 | 2 | PF15787 | |
| Domain | KCNQ_channel | 1.39e-03 | 5 | 223 | 2 | PF03520 | |
| Domain | BBOX | 1.40e-03 | 69 | 223 | 5 | SM00336 | |
| Domain | WD40 | 1.48e-03 | 268 | 223 | 10 | SM00320 | |
| Domain | - | 1.59e-03 | 71 | 223 | 5 | 4.10.45.10 | |
| Domain | AAA+_ATPase | 1.74e-03 | 144 | 223 | 7 | IPR003593 | |
| Domain | AAA | 1.74e-03 | 144 | 223 | 7 | SM00382 | |
| Domain | Kinesin_assoc | 2.06e-03 | 6 | 223 | 2 | PF16183 | |
| Domain | PH_BEACH | 2.06e-03 | 6 | 223 | 2 | PF14844 | |
| Domain | Kinesin_assoc | 2.06e-03 | 6 | 223 | 2 | IPR032405 | |
| Domain | Kinesin-like | 2.06e-03 | 6 | 223 | 2 | IPR022164 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | MYO7A KDM3B ZBED4 SH3TC1 UCKL1 A4GALT KCNQ2 DENND5A HERC2 EPN3 PRKD2 NSD2 KSR2 CHD8 DENND1A ANO8 THADA IGF2R BTBD7 TTLL4 NPRL3 LRBA MAPKBP1 CABIN1 ESPL1 LSM10 SOWAHB HTT MYBL2 | 2.83e-10 | 1105 | 229 | 29 | 35748872 |
| Pubmed | SMG1 AHCYL1 INTU IQGAP2 GATB ACTN2 NEB PSMA8 FER1L6 RPS6KC1 ZBED4 VPS13A SYCP1 DLG3 ATP11C ATP11A VARS1 RGPD5 RGPD8 NSD2 PCDHGA7 GRIA3 APOB HEATR1 ZFC3H1 FAM50A CBX5 TNN AVIL RIMS1 | 2.83e-08 | 1442 | 229 | 30 | 35575683 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | INTU KIF1A VPS13C KIF1B SMOC2 KCNIP3 KCNQ5 SH3TC1 UCKL1 SEL1L3 ACSF3 ATP11A DENND5A NSMAF CUL4A RPH3AL RASA1 NSD2 KSR2 DENND1A ANKH ANO8 THADA TBK1 NT5C2 KYAT3 RIMS1 LRBA HTT | 1.98e-07 | 1489 | 229 | 29 | 28611215 |
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 12789646 | ||
| Pubmed | The role of kindlins in cell biology and relevance to human disease. | 2.82e-07 | 3 | 229 | 3 | 19854292 | |
| Pubmed | 2.82e-07 | 3 | 229 | 3 | 12697302 | ||
| Pubmed | The Kindlins: subcellular localization and expression during murine development. | 2.82e-07 | 3 | 229 | 3 | 16876785 | |
| Pubmed | AHCYL1 RPS6KC1 SERPINE2 NF1 KCNQ5 KCNQ2 DLG3 FERMT2 NOS1 VARS1 CAP1 RGPD8 DSG1 ATG2B GRIA3 NBEA LRRC4C GABBR2 ANO8 CSE1L ATAD1 TRIM9 CNTNAP2 RIMS1 | 6.14e-07 | 1139 | 229 | 24 | 36417873 | |
| Pubmed | PRAMEF10 IQGAP2 RAPGEF5 RPS6KC1 TAOK3 MAP3K9 P2RY14 ATP11A FERMT2 UBE2Q2 PRAMEF33 ACAD9 APOB HEATR1 NCOA4 WDFY4 TRIM5 IGF2R CBX5 TTLL4 ITPRIP ACCSL ESPL1 | 9.49e-07 | 1084 | 229 | 23 | 11544199 | |
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 19147168 | ||
| Pubmed | Antiretroviral potential of human tripartite motif-5 and related proteins. | 1.12e-06 | 4 | 229 | 3 | 16828831 | |
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 21680743 | ||
| Pubmed | 1.12e-06 | 4 | 229 | 3 | 19818632 | ||
| Pubmed | The Functional Proximal Proteome of Oncogenic Ras Includes mTORC2. | AHCYL1 IQGAP2 LEMD3 NF1 PIK3CA GSTA5 DLG3 ATP11A ATP13A3 FERMT2 EPN3 FERMT1 APOB SLC6A9 IGF2R LRBA | 1.39e-06 | 569 | 229 | 16 | 30639242 |
| Pubmed | IQGAP2 SLC12A5 NF1 DLG3 HERC2 WDR1 NOS1 FERMT3 RGPD8 KSR2 GRIA3 CHD8 NBEA GABBR2 WDR91 IGF2R TBK1 NT5C2 RIMS1 CABIN1 MTSS2 | 1.88e-06 | 963 | 229 | 21 | 28671696 | |
| Pubmed | 2.27e-06 | 128 | 229 | 8 | 30995482 | ||
| Pubmed | Kindlin-2 controls TGF-β signalling and Sox9 expression to regulate chondrogenesis. | 2.36e-06 | 15 | 229 | 4 | 26151572 | |
| Pubmed | Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV. | AHCYL1 LEMD3 NT5C3A SERPINE2 NF1 VPS13A ATP11C ATP13A3 RNF145 FKBP3 CAP1 CHD8 APOB NCOA4 TGFBR2 THADA IGF2R TRIM9 FAM50A LRRC8A LRBA TMEM68 | 2.40e-06 | 1061 | 229 | 22 | 33845483 |
| Pubmed | 2.79e-06 | 5 | 229 | 3 | 26567335 | ||
| Pubmed | 4.98e-06 | 101 | 229 | 7 | 10997877 | ||
| Pubmed | PLC-gamma2 is essential for formation and maintenance of memory B cells. | 5.55e-06 | 6 | 229 | 3 | 19273623 | |
| Pubmed | 5.55e-06 | 6 | 229 | 3 | 16775307 | ||
| Pubmed | 7.56e-06 | 199 | 229 | 9 | 23382691 | ||
| Pubmed | Quantitative analysis of HSP90-client interactions reveals principles of substrate recognition. | ITK RPS6KC1 TAOK3 ZBED4 MAP3K9 CUL4B CUL4A PRKD2 KSR2 TBK1 SRPK3 MAPK4 | 7.63e-06 | 372 | 229 | 12 | 22939624 |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | KIF1A MYO7A TOPAZ1 VPS13C LAMA1 RPS6KC1 ZBED4 AGL VPS13A MAP3K9 GALNTL6 DNAH3 NBEA CPT1B TRIM9 TBK1 PRG4 | 8.90e-06 | 736 | 229 | 17 | 29676528 |
| Pubmed | KLHL41 stabilizes skeletal muscle sarcomeres by nonproteolytic ubiquitination. | 9.67e-06 | 7 | 229 | 3 | 28826497 | |
| Pubmed | 9.67e-06 | 7 | 229 | 3 | 25086068 | ||
| Pubmed | Unique features of TRIM5alpha among closely related human TRIM family members. | 9.67e-06 | 7 | 229 | 3 | 17156811 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | KDM3A AHCYL1 THNSL1 KDM3B TUBGCP3 HERC2 VARS1 RGPD5 WDR48 CUL4B CUL4A PRKD2 DSG1 ACAD9 USP6 IGF2R CSE1L ATAD1 TBK1 PHLPP2 | 1.28e-05 | 1005 | 229 | 20 | 19615732 |
| Pubmed | 1.40e-05 | 215 | 229 | 9 | 35973513 | ||
| Pubmed | IQGAP2 LEMD3 VPS13C KIF1B KDM3B VPS13A DLG3 FERMT2 TARS1 FERMT1 MUC16 NBEA APOB THADA IGF2R LRBA DKK2 | 1.78e-05 | 777 | 229 | 17 | 35844135 | |
| Pubmed | Regulation of B cell fate by chronic activity of the IgE B cell receptor. | 2.30e-05 | 9 | 229 | 3 | 27935477 | |
| Pubmed | 2.30e-05 | 9 | 229 | 3 | 22922409 | ||
| Pubmed | SMG1 MYO7A KDM3B SMOC2 NEB FER1L6 NF1 VPS13A MUC16 NBEA USP6 DNAH12 APOL6 OTOP1 MYBL2 | 2.47e-05 | 638 | 229 | 15 | 31182584 | |
| Pubmed | Synergy between PI3K signaling and MYC in Burkitt lymphomagenesis. | 3.27e-05 | 10 | 229 | 3 | 22897848 | |
| Pubmed | 3.34e-05 | 300 | 229 | 10 | 19086053 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20068106 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 19535334 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28692045 | ||
| Pubmed | Dysregulation of CUL4A and CUL4B Ubiquitin Ligases in Lung Cancer. | 4.32e-05 | 2 | 229 | 2 | 27974468 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 35311647 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 28667517 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 37431882 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22745750 | ||
| Pubmed | Discordant evolution of the adjacent antiretroviral genes TRIM22 and TRIM5 in mammals. | 4.32e-05 | 2 | 229 | 2 | 18159944 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 22180642 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 12730209 | ||
| Pubmed | UV-B-induced cutaneous inflammation and prospects for antioxidant treatment in Kindler syndrome. | 4.32e-05 | 2 | 229 | 2 | 27798104 | |
| Pubmed | KCNQ2 and KCNQ5 form heteromeric channels independent of KCNQ3. | 4.32e-05 | 2 | 229 | 2 | 35320039 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 20064923 | ||
| Pubmed | Intron-less processed Pcdhalpha genes in the central nervous system. | 4.32e-05 | 2 | 229 | 2 | 14697259 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 14675785 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 16159638 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 12470302 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15533723 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 36162506 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 38383657 | ||
| Pubmed | Oxygen modulates iron homeostasis by switching iron sensing of NCOA4. | 4.32e-05 | 2 | 229 | 2 | 37059186 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 23208300 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 29127119 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 15048721 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 10933389 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 7539720 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 21356350 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 10534398 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 36552832 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 24314652 | ||
| Pubmed | ITK/SYK translocation in angioimmunoblastic T-cell lymphoma. | 4.32e-05 | 2 | 229 | 2 | 24076779 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 17034760 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 8401589 | ||
| Pubmed | TBK1 is ubiquitinated by TRIM5α to assemble mitophagy machinery. | 4.32e-05 | 2 | 229 | 2 | 38814780 | |
| Pubmed | Brain-specific transcript variants of 5' and 3' ends of mouse VPS13A and VPS13C. | 4.32e-05 | 2 | 229 | 2 | 17196930 | |
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 24489640 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 32757223 | ||
| Pubmed | 4.32e-05 | 2 | 229 | 2 | 24573885 | ||
| Pubmed | KIF1B and NF1 are the most frequently mutated genes in paraganglioma and pheochromocytoma tumors. | 4.32e-05 | 2 | 229 | 2 | 28515046 | |
| Pubmed | TRIM34 restricts HIV-1 and SIV capsids in a TRIM5α-dependent manner. | 4.32e-05 | 2 | 229 | 2 | 32282853 | |
| Pubmed | TβRII Regulates the Proliferation of Metanephric Mesenchyme Cells through Six2 In Vitro. | 4.32e-05 | 2 | 229 | 2 | 28420207 | |
| Pubmed | 4.78e-05 | 313 | 229 | 10 | 20800603 | ||
| Pubmed | NEB PSMA8 SYCP1 TARS1 CAP1 RGPD5 CUL4B CUL4A RGPD8 DSG1 MUC16 HEATR1 CSE1L IGHG3 IGHG4 TBK1 HSP90AB2P | 5.00e-05 | 844 | 229 | 17 | 25963833 | |
| Pubmed | SMG1 KDM3A VPS13C KDM3B NSD2 TOPBP1 CHD8 ANKH TRIM9 TTLL4 CNTNAP2 LRRC8A ESPL1 | 5.53e-05 | 529 | 229 | 13 | 14621295 | |
| Pubmed | Differential expression of putative transbilayer amphipath transporters. | 7.67e-05 | 13 | 229 | 3 | 11015572 | |
| Pubmed | Mouse screen reveals multiple new genes underlying mouse and human hearing loss. | AHCYL1 PRAMEF10 MYO7A BPNT2 NF1 VPS13A DLG3 ATP11A FKBP3 PRAMEF33 DSG1 ABCB6 GRM8 KCNH4 CBX5 PUS10 TTLL4 DNAH17 MRAP2 LSM10 MTSS2 | 8.21e-05 | 1242 | 229 | 21 | 30973865 |
| Pubmed | INTU RAPGEF5 KIF1B SLC12A5 ZBED4 SEL1L3 DLG3 WDR48 LRRC4C BTBD7 MAPKBP1 | 9.04e-05 | 407 | 229 | 11 | 12693553 | |
| Pubmed | 9.72e-05 | 14 | 229 | 3 | 9373155 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 31250151 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 30768638 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 23209705 | ||
| Pubmed | VPS13A and VPS13C are lipid transport proteins differentially localized at ER contact sites. | 1.29e-04 | 3 | 229 | 2 | 30093493 | |
| Pubmed | Premature terminal differentiation protects from deregulated lymphocyte activation by ITK-Syk. | 1.29e-04 | 3 | 229 | 2 | 24376268 | |
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 28814779 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 26002977 | ||
| Pubmed | Vascular system defects and neuronal apoptosis in mice lacking ras GTPase-activating protein. | 1.29e-04 | 3 | 229 | 2 | 7477259 | |
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 32587774 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 26915459 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 22880054 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 19240021 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 34119472 | ||
| Pubmed | 1.29e-04 | 3 | 229 | 2 | 15283702 | ||
| Pubmed | Cullin4B/E3-ubiquitin ligase negatively regulates beta-catenin. | 1.29e-04 | 3 | 229 | 2 | 17954973 | |
| Interaction | CALM1 interactions | KIF1A IQGAP2 MYO7A VPS13C NT5C3A KIF1B KDM3B NUDT9 NEB KCNQ5 ZBED4 PIK3CA VPS13A SYK KCNQ2 DLG3 HERC2 PLEKHH2 FKBP3 CUL4B RASA1 NT5C2 CABIN1 HTT | 1.69e-07 | 626 | 226 | 24 | int:CALM1 |
| GeneFamily | Fermitins|Pleckstrin homology domain containing|FERM domain containing | 6.55e-07 | 3 | 158 | 3 | 561 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 6.84e-07 | 9 | 158 | 4 | 1230 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | KIF1A KIF1B ITK PLEKHH2 FERMT2 FERMT3 PRKD2 RASA1 FERMT1 PLEKHG2 PHLPP2 | 2.01e-06 | 206 | 158 | 11 | 682 |
| GeneFamily | Dyneins, axonemal | 1.22e-05 | 17 | 158 | 4 | 536 | |
| GeneFamily | Ankyrin repeat domain containing|FERM domain containing | 7.38e-05 | 50 | 158 | 5 | 1293 | |
| GeneFamily | WD repeat domain containing | 1.05e-04 | 262 | 158 | 10 | 362 | |
| GeneFamily | ATPase phospholipid transporting | 2.76e-04 | 15 | 158 | 3 | 1210 | |
| GeneFamily | Guanylate cyclase receptors|DENN/MADD domain containing | 1.31e-03 | 25 | 158 | 3 | 504 | |
| GeneFamily | Ring finger proteins|Tripartite motif containing|ARF GTPase family | 1.47e-03 | 95 | 158 | 5 | 59 | |
| GeneFamily | CD molecules|5'-nucleotidases | 1.55e-03 | 7 | 158 | 2 | 1042 | |
| GeneFamily | Cullins | 2.05e-03 | 8 | 158 | 2 | 1032 | |
| GeneFamily | Anoctamins | 3.26e-03 | 10 | 158 | 2 | 865 | |
| GeneFamily | Potassium voltage-gated channels | 5.10e-03 | 40 | 158 | 3 | 274 | |
| Coexpression | CYCLIN_D1_KE_.V1_DN | 6.97e-06 | 191 | 227 | 10 | M2647 | |
| Coexpression | GSE16385_UNTREATED_VS_12H_IL4_TREATED_MACROPHAGE_DN | VPS13C CLN5 PLEKHH2 FERMT2 NSMAF ATAD1 FAM50A MTBP PRG4 LRIT1 | 1.04e-05 | 200 | 227 | 10 | M7960 |
| Coexpression | NFE2L2.V2 | IQGAP2 GCKR GSTA5 SYK KCNQ2 CHRDL2 NSD2 FERMT1 ABCB6 USP6 PCSK6 SLC47A1 MTBP MRAP2 PRG4 | 1.62e-05 | 469 | 227 | 15 | M2870 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | ATP8A2 GREB1L KCNQ5 DNAH9 GALNTL6 DNAH3 NWD1 LRRC4C GABBR2 CNTNAP2 RIMS1 | 6.65e-10 | 159 | 228 | 11 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 LAMA1 ANO5 NEB KCNQ2 DNAH9 GALNTL6 OTOA STAB2 APOB LRRC4C | 3.12e-09 | 184 | 228 | 11 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 LAMA1 ANO5 NEB KCNQ2 DNAH9 GALNTL6 OTOA STAB2 APOB LRRC4C | 3.12e-09 | 184 | 228 | 11 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 LAMA1 ANO5 NEB KCNQ2 DNAH9 GALNTL6 OTOA STAB2 APOB LRRC4C | 3.12e-09 | 184 | 228 | 11 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | ATP8A2 GREB1L KCNQ5 DNAH9 GALNTL6 DNAH3 LRRC4C GABBR2 GRM8 CNTNAP2 | 1.28e-08 | 163 | 228 | 10 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b |
| ToppCell | COVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type | IL12RB2 ATP8A2 NEB FER1L6 ITK KCNQ5 GALNTL6 LRRC4C TFR2 CNTNAP2 | 2.03e-08 | 171 | 228 | 10 | b2e753e811a7639956994609f73efcdb62d04f82 |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-OPC-like-OPC-like-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | TOPAZ1 FAM151A SYCP1 NXF3 GALNTL6 STAB2 KCNH4 ZNF630 ACCSL SIX2 | 6.37e-08 | 193 | 228 | 10 | 315840bc48899f3a36d57b19197509de19716e3d |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | ATP8A2 SLC12A5 KCNQ5 SLF1 KSR2 GRIA3 NBEA GABBR2 CNTNAP2 RIMS1 | 8.10e-08 | 198 | 228 | 10 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 |
| ToppCell | PBMC-Control-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 4.56e-07 | 183 | 228 | 9 | 01664fce6b70a02c9d39d747b6a6aabc86d57bc2 | |
| ToppCell | Control-Epithelial_cells-Airway_goblet|Control / group, cell type (main and fine annotations) | 4.77e-07 | 184 | 228 | 9 | d92a71441e4e19f8c301999d8186f8e48e3cd162 | |
| ToppCell | facs-Aorta-Heart-3m|Aorta / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.81e-07 | 192 | 228 | 9 | 1ccc47792edf9ee23501c8e2165d11271636b66a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.43e-07 | 194 | 228 | 9 | 4a2c127c90d1fefe604fcb9e796577d21b489dd6 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.09e-07 | 196 | 228 | 9 | 676c56b44ac29f7baecb62f49bb8597cc74c0a88 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.81e-07 | 198 | 228 | 9 | af07a970afaa435c6433bb5c1cbff4c67af350c7 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.81e-07 | 198 | 228 | 9 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.81e-07 | 198 | 228 | 9 | 0ff30edfd3c133a42e8cb96e1631a1143215f808 | |
| ToppCell | Neuronal|World / cells hierarchy compared to all cells using T-Statistic | 9.57e-07 | 200 | 228 | 9 | 48d801219bc771d6c7e151dc88ca4c179988de85 | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic-Neutrophils|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 154 | 228 | 8 | 43735f7c58cac51855ded486ee8d8729a1b9909e | |
| ToppCell | LPS-IL1RA-Myeloid_granulocytic|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.33e-06 | 154 | 228 | 8 | d55fb73461885e1e02061a344ff89624ef4de487 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland-SMG_Duct|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 108 | 228 | 7 | 9c7f3e25facfb54ef0be45044999bc36438bbea0 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_submucosal-gland|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-06 | 108 | 228 | 7 | 75d635fc5bb004418db2e1328c24d96b718f10b1 | |
| ToppCell | PBMC-Mild-Lymphocyte-B-B_cell-B_intermediate-B_intermediate-10|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.46e-06 | 156 | 228 | 8 | d81e78bec5c8a3f3ec9e1447ebab2c5805b815eb | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.44e-06 | 167 | 228 | 8 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.66e-06 | 169 | 228 | 8 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 172 | 228 | 8 | 438d2e7f1897668a14d85ca70722e5d0102606dc | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 172 | 228 | 8 | 356a66cd9303470e427005cc67fdd22a2c4bf971 | |
| ToppCell | facs-Thymus-Flowthrough-3m-Myeloid-macrophage|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.04e-06 | 172 | 228 | 8 | 46fadeee483fdf8402df92ec98575a09c6c15b16 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.60e-06 | 176 | 228 | 8 | dee780cfa85234a7cd7bf440b66b84cec959893e | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.08e-06 | 179 | 228 | 8 | 6e965e424eebef50f0202cff75f458be395cfca1 | |
| ToppCell | Multiple_Sclerosis-Lymphocyte-B-B_intermediate|Multiple_Sclerosis / Disease, Lineage and Cell Type | 5.86e-06 | 188 | 228 | 8 | ee1bb0700ab70e03a63982446a33976b9200ddb6 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.08e-06 | 88 | 228 | 6 | b7b55f51af8ffa82813a4747580985a430da9ed1 | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))-|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.08e-06 | 88 | 228 | 6 | b4620e79ea80681305434707e87cb02a7c6a5e4f | |
| ToppCell | Substantia_nigra-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Rln3_(parabrachial_pigmented_nucleus_(PBP))--|Substantia_nigra / BrainAtlas - Mouse McCarroll V32 | 6.08e-06 | 88 | 228 | 6 | 7992f8e621edf464bffcb70a6cc5f3b60c1d96f8 | |
| ToppCell | COVID-19-Heart-T_cell|Heart / Disease (COVID-19 only), tissue and cell type | 6.33e-06 | 190 | 228 | 8 | e6c3a6e01fef6c5b49f72661d4fb0414ba9046bf | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-06 | 190 | 228 | 8 | 26e2237f65cb43723c5da853831b40df2982d6e4 | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.33e-06 | 190 | 228 | 8 | 2d54fca50593fbd11fe13fc2bfaf937a05db776d | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-06 | 190 | 228 | 8 | a1514d2186eb4fe569971ab22dc0c17d353fb94a | |
| ToppCell | facs-Lung-3m-Endothelial-lymphatic_endothelial-lymphatic_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.33e-06 | 190 | 228 | 8 | 0bb954a94317cfc742b9b6221bb80f8baa6d3ff1 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 6.33e-06 | 190 | 228 | 8 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-06 | 191 | 228 | 8 | 48823a97c38263f2c6e58348214f5b62773a6368 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.58e-06 | 191 | 228 | 8 | 5d24022cec293bc8d9e978ae99a109e660bb8f83 | |
| ToppCell | Entopeduncular-Neuronal-Inhibitory|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.58e-06 | 191 | 228 | 8 | 73dae4cdea86aec62393ad7303dc7375a6b3fc86 | |
| ToppCell | facs-Lung-nan-3m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.58e-06 | 191 | 228 | 8 | 0eedc66e967b1837ce2c14f8c14b3c1eba868c76 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.37e-06 | 194 | 228 | 8 | e0228f593c3493175962a4817500d4337ddc4e88 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 7.65e-06 | 195 | 228 | 8 | 9651ee03738226ee10e901f8b9ec6a417eb9c301 | |
| ToppCell | Tracheal-NucSeq-Epithelial-Epi_airway_secretory-Secretory_Goblet|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 7.94e-06 | 196 | 228 | 8 | c366f980cc04abfe1c0c14746c11810c812a42c0 | |
| ToppCell | COVID-19-Epithelial-Club,_Basal_cells|COVID-19 / Condition, Lineage and Cell class | 7.94e-06 | 196 | 228 | 8 | dd32046067d93b9484cfbf1d7826a436a3d9f0e9 | |
| ToppCell | mild-Lymphocytic-B_cells_1|Lymphocytic / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.94e-06 | 196 | 228 | 8 | 1988088dd7e1ba947339fd1331beed482955e607 | |
| ToppCell | AT2_cells-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 8.24e-06 | 197 | 228 | 8 | 5e0d222872a25bb9e9069d3dffda2844bb69874a | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.24e-06 | 197 | 228 | 8 | d83c61d2b5742e463122e1a98c7197a5b5b3d41b | |
| ToppCell | Biopsy_Other_PF-Epithelial-MUC5AC+_High|Biopsy_Other_PF / Sample group, Lineage and Cell type | 8.55e-06 | 198 | 228 | 8 | 30e6177e216f66caddcd009fafef0e07369f4d8e | |
| ToppCell | Bronchus_Control_(B.)-Endothelial-TX-Bronchial_vessel|Bronchus_Control_(B.) / Sample group, Lineage and Cell type | 8.55e-06 | 198 | 228 | 8 | dcf334d13e5b0018fee24febccfef91c9e17843b | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.55e-06 | 198 | 228 | 8 | d0ecace1fad24ce50b0935036fabb07e6c9e372d | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-06 | 198 | 228 | 8 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 8.55e-06 | 198 | 228 | 8 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.87e-06 | 199 | 228 | 8 | 3c3133d0aa65338a576634def13e7f0f5c573a10 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_airway_secretory|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 8.87e-06 | 199 | 228 | 8 | a706ad5cd5e0dc8d7e925a05e45b07d35963f294 | |
| ToppCell | (07)_Ionocytes|World / shred by cell type by condition | 8.87e-06 | 199 | 228 | 8 | 8194777d367405a7840787e977854b5c07e3bd6b | |
| ToppCell | COVID-19-kidney-Technical/muscle|kidney / Disease (COVID-19 only), tissue and cell type | 1.14e-05 | 148 | 228 | 7 | 0dbd87078f54ee1c2f8ec64e8bac9dfddb9c181e | |
| ToppCell | PBMC-Control-cDC_2|Control / Compartment, Disease Groups and Clusters | 1.42e-05 | 153 | 228 | 7 | 4ee37266b0054f276c7a73ab9220f681b9d74c71 | |
| ToppCell | E18.5-Immune-Immune_Lymphocytic_T/NK-Lymphocytic_ILC-NK-NK-NK_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.31e-05 | 165 | 228 | 7 | ec16a4979b3f203c9f66ed387a7a17bf3a1d3f86 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 165 | 228 | 7 | 0edd56e8d14eaeced9882dd9206ea93e8f402e8d | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-late_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-05 | 165 | 228 | 7 | fa3aadfff6fb1e7f142db333c60c2cba02b17e6c | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.49e-05 | 167 | 228 | 7 | 4a669eafde3582a451614ad304769b47aa1d9578 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 168 | 228 | 7 | b98af4043dfa5dfa4413e482879fad88de484675 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-hepatocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-05 | 168 | 228 | 7 | 073b53d4cee6bc8c5c6fce51cf6cd9c316478f69 | |
| ToppCell | droplet-Liver-HEPATOCYTES|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 169 | 228 | 7 | f195467438c589f87224bde7da720dea072d110c | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 169 | 228 | 7 | 7785cab967a33560830c394c918d6ce625103858 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 169 | 228 | 7 | ae85cef7ef8f761c19f4af2a23fe333641c38a92 | |
| ToppCell | facs-Lung-24m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l5|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.69e-05 | 169 | 228 | 7 | a388e53deac861a185c31e9cceddae7bcb344700 | |
| ToppCell | facs-Heart-LV-24m-Lymphocytic-B_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.69e-05 | 169 | 228 | 7 | c01bc3f2f299109086ded83dc11e98559bf1940c | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 170 | 228 | 7 | 876b84740e15399bfff2b9c7f0b80fd759bbdb3f | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.79e-05 | 170 | 228 | 7 | 1f8738acf439d893880db7e1fdc9b3615ca00c39 | |
| ToppCell | Fetal_29-31_weeks-Endothelial-endothelial_cell_of_artery-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.01e-05 | 172 | 228 | 7 | de9b11ab109d04937186c09772cec9105a935f95 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT-iNKT-MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 173 | 228 | 7 | fde1fabb8d13d05998ac3f21ecb1fde6a7a2f337 | |
| ToppCell | LPS-IL1RA-Lymphocytic_NKT-iNKT/MAIT|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.12e-05 | 173 | 228 | 7 | dcde3252ff96448d3a61039a4948c74ad321a218 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.12e-05 | 173 | 228 | 7 | 464267a2ff3f5c387b6c9c6fa4dab135a221f448 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-Natural_Killer_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 174 | 228 | 7 | 5b00a795a9dd1a77305fcac5017cb276afdc1a27 | |
| ToppCell | droplet-Lung-nan-18m-Lymphocytic-mature_NK_T_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.24e-05 | 174 | 228 | 7 | 3340b44c77f55244e3c2e2ea479d42563f937040 | |
| ToppCell | droplet-Liver-HEPATOCYTES-1m-Epithelial-Hepatocyte_(Periportal)|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.36e-05 | 175 | 228 | 7 | 5c38d4b6c03473d841e6203a7efaa6dcb2d59386 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.36e-05 | 175 | 228 | 7 | 3b5346fba617292de71963b6175e85a4f182fe30 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Dedifferentiated_Liposarcoma-4|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 3.36e-05 | 175 | 228 | 7 | 16849ea8f0985108baa2085f34c3de14a4f9f28b | |
| ToppCell | saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Monocytic-Classical_Monocyte|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.41e-05 | 119 | 228 | 6 | e6f1b9f29dc8fe6b6132c7885234c385159da393 | |
| ToppCell | systemic_lupus_erythematosus-flare-Lymphocytic_B-plasmablast|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 3.49e-05 | 176 | 228 | 7 | dc4e939a07bad21ab36181f9588df3fa662f9a92 | |
| ToppCell | Control-B_cells|Control / group, cell type (main and fine annotations) | 3.49e-05 | 176 | 228 | 7 | 9125caa27bf790f6b1b960a86c09b4bcb1b58641 | |
| ToppCell | CV-Severe-7|CV / Virus stimulation, Condition and Cluster | 3.49e-05 | 176 | 228 | 7 | 3de0c7d77210049e5616db21eed1490a17a5ec2d | |
| ToppCell | CV-Severe-7|Severe / Virus stimulation, Condition and Cluster | 3.61e-05 | 177 | 228 | 7 | 82fdd6185b368f54f03de389427cbe3071d21a99 | |
| ToppCell | COVID-19-lung-B_cells|lung / Disease (COVID-19 only), tissue and cell type | 3.61e-05 | 177 | 228 | 7 | f54691e5558091c1734ab15153a10bff15ed171e | |
| ToppCell | Adult-Immune-enucleated_erythrocyte-D231|Adult / Lineage, Cell type, age group and donor | 3.61e-05 | 177 | 228 | 7 | 15ee303fb6caea1fd645c3b777666196ce500a1c | |
| ToppCell | facs-GAT-Fat-3m-Lymphocytic-B_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.75e-05 | 178 | 228 | 7 | 5b6f7e8a930c239db1f31edfb61b2b9228d28663 | |
| ToppCell | Children_(3_yrs)-Immune-B_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.88e-05 | 179 | 228 | 7 | 31411780f1a44bf2d102f288416e97eacec4b6b6 | |
| ToppCell | (5)_Epithelial_cells-(5)_Glands_mucous|(5)_Epithelial_cells / Oesophagus cell shreds on cell class (v1) and cell subclass (v1) | 4.02e-05 | 180 | 228 | 7 | a4118adaf4b09e2ca01b662ed60e7bbf32a24d58 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 180 | 228 | 7 | 67b062f2ef7e20f392e00c646f4985c415d40de9 | |
| ToppCell | facs-Lung-EPCAM-18m-Lymphocytic-Alox5+_Lymphocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 180 | 228 | 7 | b28363626f4d2a552abde3434cc1df2e2121aba5 | |
| ToppCell | Epithelial-lung_neuroendocrine_cell_(PNEC)|World / Lineage, Cell type, age group and donor | 4.31e-05 | 182 | 228 | 7 | 57bf4ffb304324e2e392e196336a530d9f78fe0d | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_B-B_cell-B_c04-SOX5-TNFRSF1B|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.31e-05 | 182 | 228 | 7 | 9c120ddd109103ef6fac9c32b84d16a7624d0580 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.31e-05 | 182 | 228 | 7 | 3f1a666fe27dd7529c114539ed5f6b8ca585c875 | |
| ToppCell | severe_influenza-B_intermediate|World / disease group, cell group and cell class (v2) | 4.31e-05 | 182 | 228 | 7 | e633a908a2fb30ed362cf22fbb8d6839f31f1751 | |
| ToppCell | facs-Lung-EPCAM-3m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.47e-05 | 183 | 228 | 7 | ecac1cfaff7553a60305b34d6cede6973ffb5430 | |
| ToppCell | COVID-19-B_cells|COVID-19 / group, cell type (main and fine annotations) | 4.47e-05 | 183 | 228 | 7 | 2c016bb59f131a0e821853b085289a3583f0a729 | |
| Disease | Colorectal Carcinoma | ABCA13 LAMA1 ABCA8 SLC12A5 NF1 KCNQ5 SH3TC1 PIK3CA VPS13A DLG3 ATP11C P2RY14 DNAH3 ABCB6 APOB KCNH4 TGFBR2 CSE1L ATAD1 CBX5 PUS10 ZSCAN16 CTSH | 4.15e-09 | 702 | 222 | 23 | C0009402 |
| Disease | Autistic Disorder | 3.12e-05 | 261 | 222 | 10 | C0004352 | |
| Disease | mean platelet volume | IQGAP2 CYP21A2 KIF1B GCKR SMOC2 SERPINE2 ZBED4 A4GALT SYK DLG3 ATP13A3 PLCG2 RNF145 FERMT3 CUL4A PCDHGA7 TRIM5 LRRC8A ITPRIP ESPL1 HTT | 3.25e-05 | 1020 | 222 | 21 | EFO_0004584 |
| Disease | Parkinson's disease 23 (implicated_via_orthology) | 5.64e-05 | 2 | 222 | 2 | DOID:0060896 (implicated_via_orthology) | |
| Disease | choreaacanthocytosis (implicated_via_orthology) | 5.64e-05 | 2 | 222 | 2 | DOID:0050766 (implicated_via_orthology) | |
| Disease | Chronic Lymphocytic Leukemia | 5.90e-05 | 55 | 222 | 5 | C0023434 | |
| Disease | common carotid intimal medial thickness | 1.52e-04 | 67 | 222 | 5 | EFO_0004860 | |
| Disease | autosomal recessive spinocerebellar ataxia 4 (implicated_via_orthology) | 1.68e-04 | 3 | 222 | 2 | DOID:0111611 (implicated_via_orthology) | |
| Disease | Cohen syndrome (implicated_via_orthology) | 1.68e-04 | 3 | 222 | 2 | DOID:0111590 (implicated_via_orthology) | |
| Disease | diverticulitis | 1.70e-04 | 37 | 222 | 4 | EFO_1001460 | |
| Disease | childhood trauma measurement, alcohol consumption measurement | 2.00e-04 | 71 | 222 | 5 | EFO_0007878, EFO_0007979 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesterol:total lipids ratio | 2.94e-04 | 222 | 222 | 8 | EFO_0008317, EFO_0020943 | |
| Disease | stromal cell-derived factor 1 alpha measurement | 3.06e-04 | 43 | 222 | 4 | EFO_0008293 | |
| Disease | frontal pole volume measurement | 3.15e-04 | 18 | 222 | 3 | EFO_0010304 | |
| Disease | triglycerides:total lipids ratio, very low density lipoprotein cholesterol measurement | 3.22e-04 | 225 | 222 | 8 | EFO_0008317, EFO_0020947 | |
| Disease | hepatocyte growth factor measurement | 3.34e-04 | 44 | 222 | 4 | EFO_0006903 | |
| Disease | Fc receptor-like protein 4 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0801599 | |
| Disease | urinary sodium to creatinine ratio | 3.35e-04 | 4 | 222 | 2 | EFO_0009883 | |
| Disease | response to carbamazepine | 3.35e-04 | 4 | 222 | 2 | EFO_0008484 | |
| Disease | platelet-derived growth factor subunit b measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0020650 | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 3.35e-04 | 4 | 222 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | UDP-glucuronosyltransferase 2A1 measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0802186 | |
| Disease | synucleinopathy (biomarker_via_orthology) | 3.35e-04 | 4 | 222 | 2 | DOID:0050890 (biomarker_via_orthology) | |
| Disease | glia-derived nexin measurement | 3.35e-04 | 4 | 222 | 2 | EFO_0020403 | |
| Disease | metabolite measurement | CYP21A2 GCKR SLC12A5 PLEKHH2 HERPUD2 RPH3AL WDFY4 TGFBR2 IGF2R KYAT3 SLC47A1 TMEM68 CABIN1 | 3.51e-04 | 560 | 222 | 13 | EFO_0004725 |
| Disease | Gastric Adenocarcinoma | 3.65e-04 | 45 | 222 | 4 | C0278701 | |
| Disease | triacylglycerol 54:4 measurement | 3.97e-04 | 46 | 222 | 4 | EFO_0010422 | |
| Disease | very low density lipoprotein cholesterol measurement, free cholesterol:total lipids ratio | 4.81e-04 | 239 | 222 | 8 | EFO_0008317, EFO_0020945 | |
| Disease | cytotoxicity measurement, response to metformin | 5.06e-04 | 21 | 222 | 3 | EFO_0006952, GO_1901558 | |
| Disease | acute myeloid leukemia (is_marker_for) | 5.07e-04 | 49 | 222 | 4 | DOID:9119 (is_marker_for) | |
| Disease | fasting blood glucose measurement, glucose tolerance test, fasting blood insulin measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0004307, EFO_0004465, EFO_0004466 | |
| Disease | X-23639 measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0800853 | |
| Disease | 1-myristoyl-2-docosahexaenoyl-GPC (14:0/22:6) measurement | 5.55e-04 | 5 | 222 | 2 | EFO_0800454 | |
| Disease | severe acute respiratory syndrome, COVID-19 | TMPRSS13 MYO7A ATP8A2 SMOC2 ATP11A PCDHA6 LRRC4C HELQ WDFY4 TGFBR2 PCSK6 | 6.18e-04 | 447 | 222 | 11 | EFO_0000694, MONDO_0100096 |
| Disease | mean corpuscular hemoglobin concentration | INTU IQGAP2 CYP21A2 TRIM34 GCKR NEB PIK3CA A4GALT VPS13A CUL4A NCOA4 SERPINA2 TFR2 SLC6A9 INSL6 CBX5 TBK1 NT5C2 NPRL3 | 7.40e-04 | 1105 | 222 | 19 | EFO_0004528 |
| Disease | 2-myristoyl-GPC (14:0) measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0800242 | |
| Disease | 1-myristoyl-GPC (14:0) measurement | 8.29e-04 | 6 | 222 | 2 | EFO_0800221 | |
| Disease | free cholesterol to total lipids in large HDL percentage | 8.43e-04 | 56 | 222 | 4 | EFO_0022279 | |
| Disease | Brain Diseases | 8.55e-04 | 25 | 222 | 3 | C0006111 | |
| Disease | very low density lipoprotein cholesterol measurement, cholesteryl esters:total lipids ratio | 9.19e-04 | 264 | 222 | 8 | EFO_0008317, EFO_0020944 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 9.86e-04 | 150 | 222 | 6 | EFO_0004611, EFO_0020947 | |
| Disease | reticulocyte count | IQGAP2 GCKR SLC12A5 GREB1L A4GALT VPS13A ATP11A PLCG2 FERMT3 ABCB6 SERPINA2 TFR2 THADA TBK1 DNAH17 NT5C2 NPRL3 MYBL2 | 9.98e-04 | 1045 | 222 | 18 | EFO_0007986 |
| Disease | autism spectrum disorder (implicated_via_orthology) | 1.06e-03 | 152 | 222 | 6 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Encephalopathies | 1.08e-03 | 27 | 222 | 3 | C0085584 | |
| Disease | T-cell immunoglobulin and mucin domain 1 measurement | 1.15e-03 | 7 | 222 | 2 | EFO_0010812 | |
| Disease | Hyperplasia | 1.20e-03 | 28 | 222 | 3 | C0020507 | |
| Disease | Child Development Disorders, Specific | 1.33e-03 | 29 | 222 | 3 | C0085997 | |
| Disease | Child Development Deviations | 1.33e-03 | 29 | 222 | 3 | C0085996 | |
| Disease | obsolete_red blood cell distribution width | NT5C3A CYP21A2 GCKR TAOK3 A4GALT VPS13A ATP11C ATP11A CUL4A FBXO48 NPR2 ABCB6 APOB NCOA4 SERPINA2 TRIM5 TFR2 LPIN2 NT5C2 SLC47A1 MYBL2 | 1.35e-03 | 1347 | 222 | 21 | EFO_0005192 |
| Disease | Developmental Disabilities | 1.47e-03 | 30 | 222 | 3 | C0008073 | |
| Disease | neurexophilin-1 measurement | 1.53e-03 | 8 | 222 | 2 | EFO_0008244 | |
| Disease | hepatitis A virus cellular receptor 2 measurement | 1.53e-03 | 8 | 222 | 2 | EFO_0008151 | |
| Disease | Myopathies, Nemaline | 1.53e-03 | 8 | 222 | 2 | C0206157 | |
| Disease | cerebellar ataxia (implicated_via_orthology) | 1.53e-03 | 8 | 222 | 2 | DOID:0050753 (implicated_via_orthology) | |
| Disease | apolipoprotein B measurement | GCKR ABCA8 NF1 PLEKHH2 NSMAF APOB TRIM5 TFR2 HAVCR2 THADA IGF2R PCSK6 HTT | 1.64e-03 | 663 | 222 | 13 | EFO_0004615 |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 1.70e-03 | 291 | 222 | 8 | EFO_0008317, EFO_0020946 | |
| Disease | late-onset Alzheimers disease | 1.74e-03 | 292 | 222 | 8 | EFO_1001870 | |
| Disease | lifestyle measurement, alcohol consumption measurement | 1.81e-03 | 115 | 222 | 5 | EFO_0007878, EFO_0010724 | |
| Disease | creatinine measurement, glomerular filtration rate | 1.95e-03 | 117 | 222 | 5 | EFO_0004518, EFO_0005208 | |
| Disease | Hepatocellular carcinoma | 1.96e-03 | 9 | 222 | 2 | cv:C2239176 | |
| Disease | level of Sterol ester (27:1/16:1) in blood serum | 1.96e-03 | 9 | 222 | 2 | OBA_2045190 | |
| Disease | HEPATOCELLULAR CARCINOMA | 1.96e-03 | 9 | 222 | 2 | 114550 | |
| Disease | non-syndromic X-linked intellectual disability (implicated_via_orthology) | 1.96e-03 | 9 | 222 | 2 | DOID:0050776 (implicated_via_orthology) | |
| Disease | 2R,3R-dihydroxybutyrate measurement | 1.96e-03 | 9 | 222 | 2 | EFO_0800314 | |
| Disease | visual epilepsy (implicated_via_orthology) | 2.12e-03 | 34 | 222 | 3 | DOID:11832 (implicated_via_orthology) | |
| Disease | serum IgG glycosylation measurement | INTU TOPAZ1 VPS13C TRIM6 PLCG2 NSMAF STAB2 LRRC4C TRIM5 IGHG4 CNTNAP2 | 2.16e-03 | 523 | 222 | 11 | EFO_0005193 |
| Disease | Intellectual Disability | 2.19e-03 | 447 | 222 | 10 | C3714756 | |
| Disease | creatinine measurement, chronic kidney disease | 2.30e-03 | 35 | 222 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | level of Triacylglycerol (51:3) in blood serum | 2.44e-03 | 10 | 222 | 2 | OBA_2045163 | |
| Disease | long QT syndrome (implicated_via_orthology) | 2.44e-03 | 10 | 222 | 2 | DOID:2843 (implicated_via_orthology) | |
| Disease | reticulocyte measurement | IQGAP2 GCKR PIK3CA VPS13A ATP11A PLCG2 FERMT3 CUL4A ABCB6 SERPINA2 TFR2 TBK1 DNAH17 LPIN2 NT5C2 NPRL3 MYBL2 | 2.70e-03 | 1053 | 222 | 17 | EFO_0010700 |
| Disease | cholesteryl esters to total lipids in medium LDL percentage | 2.70e-03 | 37 | 222 | 3 | EFO_0022252 | |
| Disease | platelet measurement | 2.78e-03 | 315 | 222 | 8 | EFO_0005036 | |
| Disease | autosomal dominant nonsyndromic deafness (is_implicated_in) | 2.96e-03 | 11 | 222 | 2 | DOID:0050564 (is_implicated_in) | |
| Disease | level of Diacylglycerol (18:1_18:1) in blood serum | 2.96e-03 | 11 | 222 | 2 | OBA_2045170 | |
| Disease | citrate measurement | 3.02e-03 | 79 | 222 | 4 | EFO_0010114 | |
| Disease | mean reticulocyte volume | INTU IQGAP2 NT5C3A GCKR NEB PIK3CA VPS13A ACSF3 CUL4A SERPINA2 TFR2 THADA LPIN2 NPRL3 | 3.08e-03 | 799 | 222 | 14 | EFO_0010701 |
| Disease | complement C1q tumor necrosis factor-related protein 1 measurement | 3.54e-03 | 12 | 222 | 2 | EFO_0801493 | |
| Disease | nervous system disease (implicated_via_orthology) | 3.54e-03 | 12 | 222 | 2 | DOID:863 (implicated_via_orthology) | |
| Disease | Hereditary hemochromatosis | 3.54e-03 | 12 | 222 | 2 | C0392514 | |
| Disease | 1-myristoyl-2-arachidonoyl-GPC (14:0/20:4) measurement | 3.54e-03 | 12 | 222 | 2 | EFO_0800453 | |
| Disease | Hemochromatosis | 3.54e-03 | 12 | 222 | 2 | C0018995 | |
| Disease | aspartate aminotransferase measurement | IQGAP2 MYO7A ANO5 GCKR NF1 SH3TC1 VARS1 PRKD2 SERPINA2 TRIM5 WDR91 IGHG3 CNTNAP2 LRBA CTSH | 3.69e-03 | 904 | 222 | 15 | EFO_0004736 |
| Disease | free cholesterol measurement, low density lipoprotein cholesterol measurement | 3.86e-03 | 137 | 222 | 5 | EFO_0004611, EFO_0008591 | |
| Disease | autistic disorder (is_implicated_in) | 3.89e-03 | 42 | 222 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | Parkinson Disease | 3.92e-03 | 85 | 222 | 4 | C0030567 | |
| Disease | free cholesterol:total lipids ratio, intermediate density lipoprotein measurement | 4.09e-03 | 86 | 222 | 4 | EFO_0008595, EFO_0020945 | |
| Disease | liver fat measurement | 4.15e-03 | 43 | 222 | 3 | EFO_0010821 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement | 4.15e-03 | 43 | 222 | 3 | EFO_0007788, EFO_0008343 | |
| Disease | triglycerides in large LDL measurement | 4.15e-03 | 43 | 222 | 3 | EFO_0022319 | |
| Disease | cholesteryl esters to total lipids in small HDL percentage | 4.15e-03 | 43 | 222 | 3 | EFO_0022254 | |
| Disease | amyotrophic lateral sclerosis (biomarker_via_orthology) | 4.16e-03 | 13 | 222 | 2 | DOID:332 (biomarker_via_orthology) | |
| Disease | developmental and epileptic encephalopathy (implicated_via_orthology) | 4.16e-03 | 13 | 222 | 2 | DOID:0112202 (implicated_via_orthology) | |
| Disease | Prader-Willi Syndrome | 4.16e-03 | 13 | 222 | 2 | C0032897 | |
| Disease | level of Phosphatidylcholine (16:1_18:1) in blood serum | 4.16e-03 | 13 | 222 | 2 | OBA_2045082 | |
| Disease | transmembrane protein 87B measurement | 4.16e-03 | 13 | 222 | 2 | EFO_0802158 | |
| Disease | Fetal Alcohol Spectrum Disorders | 4.16e-03 | 13 | 222 | 2 | C2985290 | |
| Disease | Brittle diabetes | 4.43e-03 | 44 | 222 | 3 | C0342302 | |
| Disease | Diabetes Mellitus, Sudden-Onset | 4.43e-03 | 44 | 222 | 3 | C4554117 | |
| Disease | Diabetes, Autoimmune | 4.43e-03 | 44 | 222 | 3 | C0205734 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LESLDYKGHVNWEIL | 416 | A0A0G2JMD5 | |
| EWYTKSHGLLVQQAL | 151 | Q9H0P0 | |
| HNRSSGLYVWINLKK | 476 | Q4AC99 | |
| TSLYWLEKVSHDAIK | 226 | Q6UWY0 | |
| VASLLSQDIHFWIGK | 51 | O75366 | |
| PQASAWKKLELSHEY | 791 | Q9HCK8 | |
| FRQKASTHETWAYGK | 406 | P35609 | |
| ASKAHSIGVWQDILY | 721 | Q75V66 | |
| EYLLKWKGFSEEHNT | 36 | P45973 | |
| VRDAVDWVHYKGSLK | 201 | P49902 | |
| TYAVHVWNKKSQGTR | 311 | Q9NPC4 | |
| GYDLATLSKEWKHLK | 246 | Q9BWW8 | |
| DGKVAKINWHYADSL | 781 | Q9H7F0 | |
| DSGKNWRHVYKALTL | 66 | Q9H201 | |
| GVYILLSKKHLNWII | 241 | P12544 | |
| LKTHWTLDKYGVQAD | 71 | Q9BQL6 | |
| DKKHYILNGSKVWIT | 201 | Q9H845 | |
| YIKEFHTTGLAWSKT | 196 | Q01518 | |
| TLAKVWYNQKGFHSL | 4391 | Q86UQ4 | |
| IKYQGLEWKSSASLV | 481 | Q9NP58 | |
| KVTSWVLNTFLGYLK | 421 | O75879 | |
| EKWKNITGHTLLERY | 341 | Q4G176 | |
| GYKVSALEVEWHLLA | 481 | Q4G176 | |
| DSHALYAKKLWTAPE | 676 | P20594 | |
| KDSWKQSLHTIQGLY | 1686 | Q9P1Z9 | |
| VWKDATYSSKARLHV | 241 | Q9UBU2 | |
| TVLKFLANGWQKYLS | 586 | Q6ZW61 | |
| KEVSLVWHLYGGKDF | 1551 | Q96BY7 | |
| QFSYLEKLLLVHGAW | 856 | Q9NTI2 | |
| LVSVSAEGYKKLAIW | 406 | Q9HCE9 | |
| DYTLHLWNLLSGQEK | 931 | Q149M9 | |
| KDSGQNAWLSYLLLK | 596 | Q9Y5G6 | |
| WFHGKISKQEAYNLL | 351 | P20936 | |
| LVHWAKYLQKTGSGL | 576 | Q99666 | |
| LVHWAKYLQKTGSGL | 576 | O14715 | |
| KSHRQDYLVGNKLSW | 141 | Q7RTV2 | |
| DYLVGNKLSWADIHL | 146 | Q7RTV2 | |
| TALTRAWKGIAHKYE | 306 | Q8IWB1 | |
| LAAWKVGSGQLHYSV | 21 | Q9UN73 | |
| AQLTGLKELWLYHTA | 466 | Q8IWT6 | |
| LKELWLYHTAAKIEA | 471 | Q8IWT6 | |
| LHGSWFDGKLVTVKY | 851 | Q9Y2U8 | |
| TTWDYASDHGEKKLI | 31 | P00450 | |
| GWAKSQVIILSAKYL | 436 | Q7RTW8 | |
| SIAYALKNVSGKIWD | 161 | Q9H4D5 | |
| LYWKLSQLTHGITEL | 13411 | Q8WXI7 | |
| LAAWKVGSGQLHYSV | 21 | Q9Y5H6 | |
| KTNLTFSHIYIWGNK | 376 | Q8IZ02 | |
| NIVKLHKYWLDTSEA | 101 | Q9NSY0 | |
| KVTYTDRWGHQVKLD | 56 | Q969L4 | |
| LWGSKAHAETSYEKV | 271 | P43362 | |
| WEVLNLTGVYSGKKH | 226 | A2A368 | |
| VVAKVGHLYAAWKFS | 271 | Q9GZV7 | |
| HAEGGKLWSYISKFL | 406 | Q96S38 | |
| STVTGVHKYKWLKQN | 1611 | O95714 | |
| YKWGSVTHQSVGVVK | 2656 | O95714 | |
| YSEPKLILDLSHWKQ | 451 | P31152 | |
| GKKFDTLWQLVEHYS | 231 | P43405 | |
| FYKSLTNDWKDHLAV | 226 | Q58FF8 | |
| DLKNGATHYWSLEKL | 831 | O60333 | |
| TWKLLGSVVYAHSKE | 251 | Q9NR82 | |
| DLGNSIKHRFSTKYW | 406 | Q6VAB6 | |
| EFQISSKLHLYKGSW | 291 | Q99665 | |
| DLSLGDYSLLWKAHK | 106 | P08686 | |
| KGAILSLLGHYKWEK | 146 | P42263 | |
| KLKEWSLILYGTAEH | 621 | P29122 | |
| GTWKLLGSVVYAHSK | 216 | O43526 | |
| WVDINDKLKLYASHS | 311 | Q9BW91 | |
| YPIWEDFNSKATKLH | 26 | Q765P7 | |
| QLAAHLVYWGKAIII | 311 | Q12980 | |
| HLLKYNVGDLVWSKV | 216 | O96028 | |
| KSKVKHEWLSGRYSN | 111 | Q5FWF7 | |
| WLSKKSTYQALLDSV | 36 | Q8TET4 | |
| GHWYDLKDTSKITLV | 1986 | Q6ZR08 | |
| GALWHIYAAKDAEKI | 1611 | Q7LBC6 | |
| HYSVSKAIWDGLILL | 221 | Q9UQ05 | |
| EGWVVHYSNKDTLRK | 401 | Q9BZL6 | |
| KILAYTEGLHGKWLF | 2121 | P50851 | |
| YAARWVAKSLVKAGL | 296 | Q00266 | |
| LVLVNAVYFKGLWKS | 181 | P07093 | |
| LHSQGVLKNKWSILY | 81 | Q96CW5 | |
| ALLHSWASAEKPYLK | 116 | Q86UY5 | |
| NGAFVYLSKLKELWL | 141 | Q9HCJ2 | |
| AWKYSTDVKLSLNIL | 611 | Q8TE49 | |
| YHGWTRTTKIKFDDV | 371 | P16885 | |
| IYLWKLVKGIFHLTQ | 366 | Q6WN34 | |
| KSTEYKVIGHWTNQL | 481 | O00222 | |
| IVHYAILGIQKWSSK | 1661 | Q9C091 | |
| IHVTYIKKWDICAGN | 291 | Q9NX62 | |
| DYNTKNGTIKWHSIR | 31 | Q02413 | |
| GLLTKVKHGYSKRVW | 816 | Q8IVE3 | |
| TLHQWLKDKNKGEIY | 876 | P42336 | |
| YHSVSLVWKAPQAKN | 441 | Q9P2V4 | |
| LKDTELIYGAKHAWR | 401 | P29475 | |
| LSVKLWYDKVGHQLI | 746 | Q86UR5 | |
| STSLEKKGHVYLVGW | 321 | Q14397 | |
| SLLLNGKQIHVAYWK | 366 | Q9ULD6 | |
| GKQIHVAYWKESDKL | 371 | Q9ULD6 | |
| GLENWLLKSEKSSYQ | 256 | Q13772 | |
| YVLWKNIGRKVDSHQ | 286 | Q7RTM1 | |
| QLKEAYKWITHPLFS | 181 | Q3MIT2 | |
| SSVKLTWGTYQQLLK | 326 | Q6UWH4 | |
| APHLEEKAWSKYQTV | 376 | P20848 | |
| KLALWGEHTGQLYSK | 1916 | P04114 | |
| QLYWTHQKVTKGVSL | 866 | Q14674 | |
| SYKLGQVSIHSVWLG | 2611 | P42858 | |
| GALWHIYAAKDTEKI | 1171 | Q9Y4C1 | |
| STDVNLWYKIGHVAL | 121 | Q9Y6J0 | |
| LSKQDHYDWGLRAIK | 2011 | Q9UFH2 | |
| ARWLGTLDKKLEHYS | 3941 | Q9UFH2 | |
| HGYWFDKKDTTRLDI | 2166 | Q8TD57 | |
| SATKSKLHYKQQWGR | 836 | Q8N960 | |
| DALEVTWYHAANSKK | 66 | Q8WW52 | |
| SHAGKVVLRSWYEKN | 301 | Q14320 | |
| AFYLGKHSGRKLQWQ | 556 | Q13619 | |
| VHVKGTNVWVALYKN | 626 | P25067 | |
| KLLPEHAQTLEKYSW | 286 | P23610 | |
| KKGDVVHCWYTGTLQ | 126 | Q00688 | |
| WTHAGILLKHKYSFL | 146 | Q9HCJ1 | |
| KIKQIIEDQSGHYIW | 796 | Q92796 | |
| KQGKSALWSHLLHYQ | 811 | Q6IQ26 | |
| QDILKYLIKWGEHQL | 461 | Q9P203 | |
| SFAEIKHKYLWSEPQ | 86 | P09668 | |
| GNRHIKFWYLDDSKT | 196 | O60336 | |
| LTYIAEWKGGLLEHK | 456 | P33908 | |
| GSDKLYHQWLSTVRK | 396 | Q8TEH3 | |
| KHYQWKRVGTLTQDV | 191 | O75899 | |
| LHEWIDLIFGYKQKG | 506 | Q92636 | |
| QWRKDAGFLSYKDHL | 751 | Q9UHC6 | |
| LTVLHQDWLNGKEYK | 236 | P01860 | |
| LTVLHQDWLNGKEYK | 186 | P01861 | |
| NWTVGKLKTHLSNVY | 31 | Q9BSE4 | |
| LSKNGEWYEVLKIAA | 566 | Q9H583 | |
| KQDHYDWGLRAIKSV | 2036 | Q9NYC9 | |
| GHWYDRSKLSLKEIT | 2571 | Q9NYC9 | |
| KGIEKLYEWQHTCLT | 331 | Q8TDG4 | |
| HWTLDKYGIQADAKL | 76 | Q96AC1 | |
| WSALLEKAYAKLHGS | 201 | P20807 | |
| GTVHEKLKWAFNLYD | 161 | Q9Y2W7 | |
| WKQEAEGAIYHLASI | 21 | Q9HBV1 | |
| FYLGKHSGRKLQWQS | 711 | Q13620 | |
| WLVYSGNKHLKIATF | 251 | Q6YP21 | |
| HLGLKSLVDGYKQWS | 636 | P80192 | |
| EALKHVYLSGINSWK | 26 | Q92523 | |
| KLYGDKWNSFTILLI | 111 | O14772 | |
| DQKNGATHYWTLEKL | 791 | Q12756 | |
| TVGALKHLREWYSAK | 186 | Q96DY7 | |
| KHLREWYSAKITIAG | 191 | Q96DY7 | |
| LIKENLWSSYLTKGV | 376 | Q9H2X9 | |
| LVHLGYWLNKDKVAI | 376 | Q08881 | |
| KLQTGWSVHTYQTEK | 26 | Q9UNE2 | |
| KVDVYLWLGSIKHAS | 776 | Q2WGJ9 | |
| GLWSLYKDKHLVKSA | 26 | Q49A17 | |
| EKTWNLGLSNAKLSY | 686 | P11717 | |
| KIHKNSSTYWEGKAD | 276 | P26639 | |
| RIYHQLKKLGSSLDW | 426 | P26640 | |
| SGKHYWEVDVSKKTA | 346 | Q9BYJ4 | |
| TESLLRLEWHIKGKY | 441 | Q6YHU6 | |
| VVWAKHVAEKNGYLG | 861 | Q68CR1 | |
| IVSKYRTHHGASLWK | 11 | A6NKH3 | |
| ILDDGGDLTHWVYKK | 226 | O43865 | |
| SDGSWLKLNLHKKYD | 596 | Q13576 | |
| YLVKEIEKLCGHANW | 36 | Q9Y581 | |
| YGTKQWTLIAKHLKG | 101 | P10244 | |
| WYSHSKEKIQNLSLI | 226 | Q8TDQ0 | |
| LLSDGKWHTVKTDYV | 2791 | P25391 | |
| YKLLASKSESIWVQA | 751 | Q8NFP9 | |
| IWVQALKVLGYFLKH | 761 | Q8NFP9 | |
| VLASSYDTAWKKHDL | 3161 | Q96Q15 | |
| KVLHLVSQWIALYKD | 146 | Q92565 | |
| ELGKQYWLITAFHAK | 316 | P37173 | |
| KLFVTHTVDELLWGY | 166 | Q14108 | |
| VLELWHGVTYAFKDL | 101 | Q86YJ6 | |
| SYSGKQTHEKWQDIL | 56 | Q9H2K8 | |
| KEKEAHAWLQAGKIY | 1066 | Q8TE82 | |
| LWQKDHLLSVSLSGY | 286 | O75083 | |
| KSELGRKWHKASNYI | 176 | Q15391 | |
| KDFLTGYTALHWIAK | 626 | A6NEL2 | |
| GQIVAALSTAKYKNW | 1241 | Q92954 | |
| LFLYILGKKLHQATW | 231 | Q96FL8 | |
| VLGHQLLKWIIKSNY | 166 | Q9UPE1 | |
| FLKKKWGIGYHLSLQ | 701 | O94911 | |
| HGSAKFYISDLWKVT | 136 | Q6P4H8 | |
| TLTDKWYGESQKLAA | 161 | Q8NBU5 | |
| VWEFKYGDLLGHLKI | 101 | O75503 | |
| KTEHIGFVIYSWRKS | 21 | Q8IZS7 | |
| VTAIKQGYEDWLRHK | 106 | P98196 | |
| KKAWTEHQEYGLIID | 741 | Q8NB49 | |
| SGKHYWEVDVSKKTA | 356 | Q9C035 | |
| LSSGKHYWEVDVKDS | 336 | I1YAP6 | |
| LINDSLYDWHVKLQK | 231 | Q8WVN8 | |
| SVNWKHKDAAIYLVT | 421 | P55060 | |
| IFKTLHGNIWYEKDG | 1331 | Q96RL7 | |
| WDKSLLKIYSGSSHQ | 231 | Q9BYE2 | |
| IWKSGGDLTLHYRQK | 661 | Q8TAF3 | |
| YKGAVAQVLWHLFSI | 296 | Q5GH72 | |
| AEGYRKLSLKGHNDW | 351 | Q6ZMY6 | |
| KSRGVYWHSELQKGL | 441 | Q9NX65 | |
| KEAYSHNLWDGARKT | 81 | Q96MH6 | |
| EGLKAHKYSIVIGFW | 36 | Q96G30 | |
| ILGNKALWEHLSYTE | 981 | Q6ZVD8 | |
| YTVHVWAQKGDRESK | 596 | Q9UQP3 | |
| VVHWYFKLLDKNSSG | 351 | Q9H3U7 | |
| SVDHGISKDKRDYLW | 826 | Q15431 | |
| GWSTNLNEYKKIHTG | 191 | Q8TF20 | |
| SFGWSTNLNEYKKIH | 721 | Q8TF20 | |
| WQHYLASEKKSLASR | 2171 | Q6ZS81 | |
| LGNWTYKAHVMSSLK | 81 | A6NDX5 | |
| HAKWEQATKLILNYP | 781 | P21359 | |
| LESLDYKGHVNWEIL | 416 | O60809 | |
| SVLKVWHGAYNSGLL | 56 | P48067 | |
| WYSTHSLVGDKNIIL | 46 | Q8IYQ7 | |
| AQKAKYHLCSAGWLE | 2236 | Q8WWQ8 | |
| QALKVEAKLEHWYIT | 571 | Q709C8 | |
| TWTYAANVGEHDLLK | 3021 | Q709C8 | |
| KGYRQHWVVFKETTL | 371 | Q86UX7 | |
| CAAGKWILTKDYIIH | 61 | Q9BQI6 | |
| WILTKDYIIHSAKSG | 66 | Q9BQI6 | |
| AKLQQLWLKAHYIEA | 81 | Q9NPC8 | |
| APKDNSLYSVLKIWH | 106 | Q2M218 | |
| KTGFSKGIHYWELTV | 571 | Q9C026 | |
| KEQVYSLEHCSALKW | 1661 | Q8N9V7 | |
| KGLLIIKAEDHYWGQ | 11 | Q9H4T2 | |
| TTHSRKKDWKTLYGA | 186 | Q9NWZ5 | |
| LKYHLLLQELGKHWA | 241 | Q9H7P9 | |
| YHAWKANAIGRSAKT | 161 | Q8TAA3 | |
| YHGNKLKGVDLLRSW | 1056 | Q14679 | |
| FHAGCLKKWLYVQET | 556 | Q96MT1 | |
| WNIHKSGLKVSEYSL | 631 | A4D1P6 | |
| EKYLASVAAGKWVLH | 1316 | Q92547 | |
| STEWLEGYLSVLHLK | 486 | Q9UP52 | |
| ENPSHVQLWLKLAYK | 1356 | O60293 | |
| LGEWETYKHSSKLID | 81 | P35125 | |
| RKDHQKKYGATVDLW | 191 | Q9UHD2 | |
| SSGKHYWEVDVAKKT | 351 | Q9C030 | |
| GTSFIWSSYLIQHKK | 406 | Q8WXB4 | |
| WKHFYLSPLDNSKAV | 291 | O75132 | |
| ESHAGKVVLRSWYEK | 286 | Q9Y247 | |
| HGKAIKVSYDEWNRK | 1316 | P35573 | |
| QWENVHKKVISSGYE | 226 | Q6ZMR3 | |
| QLGKDWTHQGIAKLY | 706 | Q92539 | |
| WAQLAIAAHKKGIYA | 1431 | Q13402 | |
| DWKRSIVAYFNKHAG | 2076 | Q13402 | |
| SDNLYKSDLQWLKGI | 2651 | P20929 |